Search

everythinglearnresearchcommunity

for

Search:↓

No link found between Coxsackie viruses and pemphigus.

AGEs may cause hair loss by increasing inflammation in hair follicles.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

New alopecia treatments aim for better results and fewer side effects.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Created microspheres show potential for safe and effective use in prostate artery embolization.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.